Table 5.4.
Heart disease | In utero outcome | In utero follow-up | Delivery | Postnatal assessment |
---|---|---|---|---|
PS PAIVS AS Ebsteins anomaly |
Risk of ventricular hypoplasia Risk of ventricular dysfunction or fetal hydrops Risk of circular shunt Risk of fetal arrhythmia |
Repeat the study every 2 to 4 weeks is
recommended If signs of in utero progression, consider fetal intervention between 22 and 32 weeks If circular shunt, consider induced ductal constriction |
Without hydrops, induced vaginal delivery or programmed
C-section With hydrops, programmed C-section Level 2 or 3 center |
Immediate neonatal cardiac assessment PAIVS requires neonatal treatment Severe or critical PS and AS, may require neonatal treatment Ebsteins anomaly needs treatment if pulmonary atresia and lung hypoplasia |
AS: aortic stenosis; PAIVS: pulmonary atresia with intact interventricular septum; PS: pulmonary stenosis.